MedTrace Logo

The Effect of Eye Exercises in Parkinson's Disease

NCT07525973 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2026-05-13

No results posted yet for this study

Summary

Parkinson's disease is commonly associated with impaired gait, postural instability, reduced physical function, and increased concern about falling, all of which contribute substantially to disability and reduced quality of life. Exercise-based rehabilitation is increasingly recommended as a core non-pharmacological strategy for improving mobility and balance in people with Parkinson's disease. In parallel, recent clinical and neurorehabilitation research suggests that eye-movement and gaze-stabilization training may influence postural control, visuomotor integration, and movement performance in neurological disorders, including Parkinson's disease. This randomized controlled trial will evaluate whether a supervised in-center eye-exercise program can improve physical function, balance, and fall-related concern in patients with Parkinson's disease.

Conditions

  • Parkinson Disease

Interventions

BEHAVIORAL

Supervised In-Center Eye Exercises

The participants in the study group will perform the eye-exercise program in a supervised rehabilitation/clinic setting. The exercises will initially be performed in a seated position, with selected tasks progressed to standing positions as tolerated and considered safe by the supervising therapist. The exercises will be administered face-to-face by trained study personnel. The program will include progressive visual fixation, smooth pursuit, saccadic eye movements, convergence/divergence, gaze stabilization, and combined eye-head coordination tasks, with gradual progression in speed and complexity according to participant tolerance and safety.

Sponsors & Collaborators

  • Pardis Specialized Wellness Institute

    lead OTHER

Principal Investigators

  • Mohammad Ali Tabibi, Dr · Pardis Specialized Wellness Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2026-09-01
Completion
2026-09-01

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07525973 on ClinicalTrials.gov